RxSight Inc (RXST)
61.15
+0.56
(+0.92%)
USD |
NASDAQ |
May 24, 16:00
61.16
+0.01
(+0.02%)
After-Hours: 20:00
RxSight Cash from Financing (TTM): 4.211M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.211M |
| December 31, 2023 | 61.52M |
| September 30, 2023 | 64.27M |
| June 30, 2023 | 72.05M |
| March 31, 2023 | 71.74M |
| December 31, 2022 | 6.332M |
| September 30, 2022 | 0.429M |
| Date | Value |
|---|---|
| June 30, 2022 | 121.43M |
| March 31, 2022 | 131.10M |
| December 31, 2021 | 137.34M |
| September 30, 2021 | 161.27M |
| June 30, 2021 | 40.77M |
| March 31, 2021 | 31.31M |
| December 31, 2020 | 25.24M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.429M
Minimum
Sep 2022
161.27M
Maximum
Sep 2021
66.36M
Average
62.90M
Median
Cash from Financing (TTM) Benchmarks
| Alphatec Holdings Inc | 285.44M |
| Masimo Corp | -48.40M |
| Tactile Systems Technology Inc | -28.89M |
| iRhythm Technologies Inc | 512.56M |
| Shockwave Medical Inc | 522.00M |